Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat
Cited by 18

The DOI matches its Crossref record; 18 of the 18 references it cites were found in a registry or an index.

Process Parameter Development for the Scaled Generation of Stem Cell-Derived Pancreatic Endocrine Cells

Iworima, Diepiriye G., Rieck, Sebastian, Kieffer, Timothy J. · 2021 · Stem Cells Translational Medicine

Abstract

Diabetes is a debilitating disease characterized by high blood glucose levels. The global prevalence of this disease has been projected to reach 700 million adults by the year 2045. Type 1 diabetes represents about 10% of the reported cases of diabetes. Although islet transplantation can be a highly effective method to treat type 1 diabetes, its widespread application is limited by the paucity of cadaveric donor islets. The use of pluripotent stem cells as an unlimited cell source to generate insulin-producing cells for implant is a promising alternative for treating diabetes. However, to be clinically relevant, it is necessary to manufacture these stem cell-derived cells at sufficient scales. Significant advances have been made in differentiation protocols used to generate stem cell-derived cells capable of reversing diabetes in animal models and for testing in clinical trials. We discuss the potential of both stem cell-derived pancreatic progenitors and more matured insulin-producing cells to treat diabetes. We discuss the need for rigorous bioprocess parameter optimization and identify some critical process parameters and strategies that may influence the critical quality attributes of the cells with the goal of facilitating scalable manufacturing of human pluripotent stem cell-derived pancreatic endocrine cells.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1002/sctm.21-0161

Cites

18 of 18 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 18 references

Research works printed but not linked: 81

  1. IDF, 2019, IDF Diabetes Atlas 9th edition 2019
  2. Bommer, 2018, Global economic burden of diabetes in adults: projections from 2015 to 2030, Diabetes Care, 41, 963, 10.2337/dc17-1962 · DOI · Paper page
  3. Bliss, 1982, Banting's, Best's and Collip's accounts of the discovery of insulin, Bull Hist Med, 56, 554
  4. Shapiro, 2000, Islet transplantation in seven patients with type 1 diabetes mellitus using a glucocorticoid-free immunosuppressive regimen, N Engl J Med, 343, 230, 10.1056/NEJM200007273430401 · DOI · Paper page
  5. Andres, 2016, Clinical islet isolation and transplantation outcomes with deceased cardiac death donors are similar to neurological determination of death donors, Transpl Int, 29, 34, 10.1111/tri.12650 · doi:10.1111/tri.12650
  6. Markmann, 2003, The use of non-heart-beating donors for isolated pancreatic islet transplantation, Transplantation, 75, 1423, 10.1097/01.TP.0000061119.32575.F4 · DOI
  7. D'Amour, 2006, Production of pancreatic hormone-expressing endocrine cells from human embryonic stem cells, Nat Biotechnol, 24, 1392, 10.1038/nbt1259 · DOI · Paper page
  8. D'Amour, 2005, Efficient differentiation of human embryonic stem cells to definitive endoderm, Nat Biotechnol, 23, 1534, 10.1038/nbt1163 · DOI · Paper page
  9. Henry, 2018, Initial clinical evaluation of VC-01TM combination product—a stem cell–derived islet replacement for type 1 diabetes (T1D), Diabetes, 67, 10.2337/db18-138-OR · DOI
  10. Pullen, 2018, Cell-derived pancreatic progenitor cells have now been transplanted into patients: report from IPITA 2018, Am J Transplant, 18, 1581, 10.1111/ajt.14954 · DOI
  11. Keymeulen, 2021, 196-LB: stem cell-derived islet replacement therapy (VC-02) demonstrates production of C-peptide in patients with type 1 diabetes (T1D) and hypoglycemia unawareness, Diabetes, 70, 10.2337/db21-196-LB · DOI
  12. Kelly, 2011, Cell-surface markers for the isolation of pancreatic cell types derived from human embryonic stem cells, Nat Biotechnol, 29, 750, 10.1038/nbt.1931 · DOI · Paper page
  13. Schulz, 2012, A scalable system for production of functional pancreatic progenitors from human embryonic stem cells, PLoS One, 7, 10.1371/journal.pone.0037004 · DOI · Paper page
  14. Motté, 2014, Composition and function of macroencapsulated human embryonic stem cell-derived implants: comparison with clinical human islet cell grafts, Am J Physiol Metab, 307, E838
  15. Saber, 2018, Sex differences in maturation of human embryonic stem cell–derived β cells in mice, Endocrinology, 159, 1827, 10.1210/en.2018-00048 · DOI
  16. Bruin, 2016, Hypothyroidism impairs human stem cell-derived pancreatic progenitor cell maturation in mice, Diabetes, 65, 1297, 10.2337/db15-1439 · DOI
  17. Bruin, 2015, Accelerated maturation of human stem cell-derived pancreatic progenitor cells into insulin-secreting cells in immunodeficient rats relative to mice, Stem Cell Rep, 5, 1081, 10.1016/j.stemcr.2015.10.013 · DOI
  18. Millman, 2016, Generation of stem cell-derived β-cells from patients with type 1 diabetes, Nat Commun, 7
  19. Wang, 2014, Differentiation of iPSCs into insulin-producing cells via adenoviral transfection of PDX-1, NeuroD1 and MafA, Diabetes Res Clin Pract, 104, 383, 10.1016/j.diabres.2014.03.017 · DOI
  20. Saxena, 2016, A programmable synthetic lineage-control network that differentiates human IPSCs into glucose-sensitive insulin-secreting beta-like cells, Nat Commun, 7, 1, 10.1038/ncomms11247 · DOI
  21. Zhu, 2019, Targeted derivation of organotypic glucose- and GLP-1-responsive β cells prior to transplantation into diabetic recipients, Stem Cell Rep, 13, 307, 10.1016/j.stemcr.2019.07.006 · DOI
  22. Vertex Announces FDA, 2021, Clearance of investigational new drug (IND) application for VX-880, a novel cell therapy for the treatment of Type 1 diabetes (T1D) | Vertex Newsroom
  23. Shapiro, 2017, Clinical pancreatic islet transplantation, Nat Rev Endocrinol, 13, 268, 10.1038/nrendo.2016.178 · DOI · Paper page
  24. Docherty, 2007, Embryonic stem cell therapy for diabetes mellitus, Semin Cell Dev Biol, 18, 827, 10.1016/j.semcdb.2007.09.009 · DOI
  25. Lock, 2007, Stem/progenitor cell sources of insulin-producing cells for the treatment of diabetes, Tissue Eng, 13, 1399, 10.1089/ten.2007.0047 · DOI
  26. Lipsitz, 2016, Quality cell therapy manufacturing by design, Nat Biotechnol, 34, 393, 10.1038/nbt.3525 · DOI · Paper page
  27. Witcher, 2020, Why controlling CQAs isn't good enough for gene cell therapies
  28. Takahashi, 2007, Induction of pluripotent stem cells from adult human fibroblasts by defined factors, Cell, 131, 861, 10.1016/j.cell.2007.11.019 · DOI · Paper page
  29. Yu, 2007, Induced pluripotent stem cell lines derived from human somatic cells, Science (80-), 318, 1917, 10.1126/science.1151526 · DOI · Paper page
  30. Chin, 2009, Induced pluripotent stem cells and embryonic stem cells are distinguished by gene expression signatures, Cell Stem Cell, 5, 111, 10.1016/j.stem.2009.06.008 · DOI · Paper page
  31. Deng, 2009, Targeted bisulfite sequencing reveals changes in DNA methylation associated with nuclear reprogramming, Nat Biotechnol, 27, 353, 10.1038/nbt.1530 · DOI · Paper page
  32. Kim, 2011, Donor cell type can influence the epigenome and differentiation potential of human induced pluripotent stem cells, Nat Biotechnol, 29, 1117, 10.1038/nbt.2052 · DOI · Paper page
  33. Yamanaka, 2012, Induced pluripotent stem cells: past, present, and future, Cell Stem Cell, 10, 678, 10.1016/j.stem.2012.05.005 · DOI · Paper page
  34. Moradi, 2019, Research and therapy with induced pluripotent stem cells (iPSCs): social, legal, and ethical considerations, Stem Cell Res Ther, 10, 1, 10.1186/s13287-019-1455-y · DOI · Paper page
  35. Stevens, 2018, Human pluripotent stem cell-derived engineered tissues: clinical considerations, Cell Stem Cell, 22, 294, 10.1016/j.stem.2018.01.015 · DOI
  36. Stacey, 2019, Stem cell culture conditions and stability: a joint workshop of the PluriMes Consortium and Pluripotent Stem Cell Platform, Regen Med, 14, 243, 10.2217/rme-2019-0001 · DOI
  37. 2007, Why do scientists need many lines of embryonic stem cells?, Nat Rep Stem Cells
  38. Beers, 2012, Passaging and colony expansion of human pluripotent stem cells by enzyme-free dissociation in chemically defined culture conditions, Nat Protoc, 7, 2029, 10.1038/nprot.2012.130 · DOI · Paper page
  39. Zakrzewski, 2019, Stem cells: past, present, and future, Stem Cell Res Ther, 10, 1, 10.1186/s13287-019-1165-5 · DOI · Paper page
  40. Bai, 2015, Temporal analysis of genome alterations induced by single-cell passaging in human embryonic stem cells, Stem Cells Dev, 24, 653, 10.1089/scd.2014.0292 · DOI
  41. Borys, 2021, Overcoming bioprocess bottlenecks in the large-scale expansion of high-quality hiPSC aggregates in vertical-wheel stirred suspension bioreactors, Stem Cell Res Ther, 12, 55, 10.1186/s13287-020-02109-4 · DOI
  42. Cruvinel, 2020, Long-term single-cell passaging of human iPSC fully supports pluripotency and high-efficient trilineage differentiation capacity, SAGE open Med, 8, 10.1177/2050312120966456 · DOI
  43. Thomson, 2008, Human embryonic stem cells passaged using enzymatic methods retain a normal karyotype and express CD30, Cloning Stem Cells, 10, 89, 10.1089/clo.2007.0072 · DOI
  44. Manstein, 2021, High density bioprocessing of human pluripotent stem cells by metabolic control and in silico modeling, Stem Cells Translational Medicine, 10, 1063, 10.1002/sctm.20-0453 · DOI
  45. Veres, 2019, Charting cellular identity during human in vitro β-cell differentiation, Nat, 2019, 368, 10.1038/s41586-019-1168-5 · DOI · Paper page
  46. Sahabian, 2021, Production and cryopreservation of definitive endoderm from human pluripotent stem cells under defined and scalable culture conditions, Nat Protoc, 16, 1581, 10.1038/s41596-020-00470-5 · DOI
  47. Chen, 2010, Actin-myosin contractility is responsible for thcelle reduced viability of dissociated human embryonic stem cells, Cell Stem Cell, 7, 240, 10.1016/j.stem.2010.06.017 · DOI · Paper page
  48. Lipsitz, 2018, Chemically controlled aggregation of pluripotent stem cells, Biotechnol Bioeng, 115, 2061, 10.1002/bit.26719 · DOI
  49. Chen, 2021, A versatile polypharmacology platform promotes cytoprotection and viability of human pluripotent and differentiated cells, Nat Methods, 18, 528, 10.1038/s41592-021-01126-2 · DOI · Paper page
  50. Komatsu, 2017, Oxygen environment and islet size are the primary limiting factors of isolated pancreatic islet survival, PLoS One, 12, e0183780, 10.1371/journal.pone.0183780 · DOI
  51. Sachlos, 2008, Embryoid body morphology influences diffusive transport of inductive biochemicals: a strategy for stem cell differentiation, Biomaterials, 29, 4471, 10.1016/j.biomaterials.2008.08.012 · DOI
  52. Nath, 2017, Size- and time-dependent growth properties of human induced pluripotent stem cells in the culture of single aggregate, J Biosci Bioeng, 124, 469, 10.1016/j.jbiosc.2017.05.006 · DOI
  53. Kato, 2018, Comparison of growth kinetics between static and dynamic cultures of human induced pluripotent stem cells, J Biosci Bioeng, 125, 736, 10.1016/j.jbiosc.2018.01.002 · DOI
  54. Kim, 2018, Adv Exper Med and Bio, 19
  55. Kim, 2018, Role of cell-secreted extracellular matrix formation in aggregate formation and stability of human induced pluripotent stem cells in suspension culture, J Biosci Bioeng, 127, 372, 10.1016/j.jbiosc.2018.08.010 · DOI
  56. Nogueira, 2019, Strategies for the expansion of human induced pluripotent stem cells as aggregates in single-use Vertical-Wheel™ bioreactors, J Biol Eng, 13, 1, 10.1186/s13036-019-0204-1 · DOI
  57. Toyoda, 2015, Cell aggregation optimizes the differentiation of human ESCs and iPSCs into pancreatic bud-like progenitor cells, Stem Cell Res, 14, 185, 10.1016/j.scr.2015.01.007 · DOI
  58. Pipeleers, 1985, Interplay of nutrients and hormones in the regulation of insulin release, Endocrinology, 117, 824, 10.1210/endo-117-3-824 · DOI · Paper page
  59. Holz, 1993, Pancreatic beta-cells are rendered glucose-competent by the insulinotropic hormone glucagon-like peptide-1(7-37), Nature, 361, 362, 10.1038/361362a0 · DOI · Paper page
  60. Capozzi, 2019, β-Cell tone is defined by proglucagon peptides through cyclic AMP signaling, JCI Insight, 4, e126742, 10.1172/jci.insight.126742 · DOI · Paper page
  61. Svendsen, 2018, Insulin secretion depends on intra-islet glucagon signaling, Cell Rep, 25, 1127, 10.1016/j.celrep.2018.10.018 · DOI · Paper page
  62. Chowdhury, 2013, Functional differences between aggregated and dispersed insulin-producing cells, Diabetologia, 56, 1557, 10.1007/s00125-013-2903-3 · DOI
  63. King, 2007, Normal relationship of beta- and non-beta-cells not needed for successful islet transplantation, Diabetes, 56, 2312, 10.2337/db07-0191 · DOI
  64. Pipeleers, 1991, Transplantation of purified islet cells in diabetic rats: I. Standardization of islet cell grafts, Diabetes, 40, 908, 10.2337/diab.40.7.908 · doi:10.2337/diab.40.7.908
  65. Kieffer, 2016, Closing in on mass production of mature human beta cells, Cell Stem Cell, 18, 699, 10.1016/j.stem.2016.05.014 · DOI
  66. Ionescu-Tirgoviste, 2015, A 3D map of the islet routes throughout the healthy human pancreas, Sci Rep, 5, 10.1038/srep14634 · DOI · Paper page
  67. Kim, 2009, Islet architecture: a comparative study, Islets, 1, 129, 10.4161/isl.1.2.9480 · DOI · Paper page
  68. Lehmann, 2007, Superiority of small islets in human islet transplantation, Diabetes, 56, 594, 10.2337/db06-0779 · DOI · Paper page
  69. Macgregor, 2006, Small rat islets are superior to large islets in in vitro function and in transplantation outcomes Rat Islet Isolation and Separation Procedures, Am J Physiol Endocrinol Metab, 290, 771, 10.1152/ajpendo.00097.2005 · DOI · Paper page
  70. Fujita, 2011, Large human islets secrete less insulin per islet equivalent than smaller islets in vitro, Islets, 3, 1, 10.4161/isl.3.1.14131 · DOI
  71. Su, 2010, Small islets are essential for successful intraportal transplantation in a diabetes mouse model, Scand J Immunol, 72, 504, 10.1111/j.1365-3083.2010.02466.x · DOI
  72. Farhat, 2013, Small human islets comprised of more β-cells with higher insulin content than large islets, Islets, 5, 87, 10.4161/isl.24780 · DOI
  73. Yu, 2018, Bioengineered human pseudoislets form efficiently from donated tissue, compare favourably with native islets in vitro and restore normoglycaemia in mice, Diabetologia, 61, 2016, 10.1007/s00125-018-4672-5 · DOI
  74. Ichihara, 2016, Size effect of engineered islets prepared using microfabricated wells on islet cell function and arrangement, Heliyon, 2, 10.1016/j.heliyon.2016.e00129 · DOI
  75. Cogger, 2017, Glycoprotein 2 is a specific cell surface marker of human pancreatic progenitors, Nat Commun, 8, 331, 10.1038/s41467-017-00561-0 · DOI · Paper page
  76. Ameri, 2017, Efficient generation of glucose-responsive beta cells from isolated GP2+ human pancreatic progenitors, Cell Rep, 19, 36, 10.1016/j.celrep.2017.03.032 · DOI
  77. Stock, 2019, Conformal coating of stem cell-derived islets for β cell replacement in type 1 diabetes, Stem Cell Rep, 14, 91, 10.1016/j.stemcr.2019.11.004 · DOI · Paper page
  78. Bandeiras, 2019, Bringing stem cell-based therapies for type 1 diabetes to the clinic: early insights from bioprocess economics and cost-effectiveness analysis, Biotechnol J, 14, 10.1002/biot.201800563 · DOI
  79. Archibald, 2015, Using the cost-effectiveness of allogeneic islet transplantation to inform induced pluripotent stem cell-derived β-cell therapy reimbursement, Regen Med, 10, 959, 10.2217/rme.15.59 · DOI
  80. Bandeiras, 2019, Economics of beta-cell replacement therapy, Curr Diab Rep, 19, 1, 10.1007/s11892-019-1203-9 · DOI
  81. Iworima, 2021, Process parameter development for the scaled generation of stem cell-derived pancreatic endocrine cells, STEM CELLS Transl Med, 10, 1459, 10.1002/sctm.21-0161

Cited by

See all 18

Metadata

Authors
Iworima, D. G., Rieck, S., & Kieffer, T. J.
Venue
Stem Cells Translational Medicine
Published
2021-08-13
Volume
10
Issue
11
Pages
1459-1469
ISSN
  • 2157-6564
  • 2157-6580
Cited by
18
References
18
Language
en

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Process Parameter Development for the Scaled Generation of Stem Cell-Derived Pancreatic Endocrine Cells. https://app.cochat.ai/papers/10.1002/sctm.21-0161
The paper
Iworima, D. G., Rieck, S., & Kieffer, T. J. (2021). Process Parameter Development for the Scaled Generation of Stem Cell-Derived Pancreatic Endocrine Cells. Stem Cells Translational Medicine. https://doi.org/10.1002/sctm.21-0161

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.